Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Payables (2022 - 2025)

Envoy Medical's Payables history spans 4 years, with the latest figure at $5.3 million for Q3 2025.

  • For Q3 2025, Payables rose 202.05% year-over-year to $5.3 million; the TTM value through Sep 2025 reached $5.3 million, up 202.05%, while the annual FY2024 figure was $2.3 million, 50.77% up from the prior year.
  • Payables for Q3 2025 was $5.3 million at Envoy Medical, up from $3.0 million in the prior quarter.
  • Across five years, Payables topped out at $7.4 million in Q3 2023 and bottomed at $658899.0 in Q1 2022.
  • The 4-year median for Payables is $1.6 million (2024), against an average of $2.2 million.
  • The largest annual shift saw Payables skyrocketed 588.95% in 2023 before it plummeted 76.2% in 2024.
  • A 4-year view of Payables shows it stood at $2.6 million in 2022, then tumbled by 40.3% to $1.6 million in 2023, then skyrocketed by 50.77% to $2.3 million in 2024, then skyrocketed by 126.5% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Payables are $5.3 million (Q3 2025), $3.0 million (Q2 2025), and $1.7 million (Q1 2025).